Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis
- PMID: 20116841
- DOI: 10.1016/S0140-6736(10)60101-8
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis
Erratum in
- Lancet. 2014 Oct 25;384(9953):1504
Abstract
Background: Emergency contraception can prevent unintended pregnancies, but current methods are only effective if used as soon as possible after sexual intercourse and before ovulation. We compared the efficacy and safety of ulipristal acetate with levonorgestrel for emergency contraception.
Methods: Women with regular menstrual cycles who presented to a participating family planning clinic requesting emergency contraception within 5 days of unprotected sexual intercourse were eligible for enrolment in this randomised, multicentre, non-inferiority trial. 2221 women were randomly assigned to receive a single, supervised dose of 30 mg ulipristal acetate (n=1104) or 1.5 mg levonorgestrel (n=1117) orally. Allocation was by block randomisation stratified by centre and time from unprotected sexual intercourse to treatment, with allocation concealment by identical opaque boxes labelled with a unique treatment number. Participants were masked to treatment assignment whereas investigators were not. Follow-up was done 5-7 days after expected onset of next menses. The primary endpoint was pregnancy rate in women who received emergency contraception within 72 h of unprotected sexual intercourse, with a non-inferiority margin of 1% point difference between groups (limit of 1.6 for odds ratio). Analysis was done on the efficacy-evaluable population, which excluded women lost to follow-up, those aged over 35 years, women with unknown follow-up pregnancy status, and those who had re-enrolled in the study. Additionally, we undertook a meta-analysis of our trial and an earlier study to assess the efficacy of ulipristal acetate compared with levonorgestrel. This trial is registered with ClinicalTrials.gov, number NCT00551616.
Findings: In the efficacy-evaluable population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipristal acetate, n=844; levonorgestrel, n=852). There were 15 pregnancies in the ulipristal acetate group (1.8%, 95% CI 1.0-3.0) and 22 in the levonorgestrel group (2.6%, 1.7-3.9; odds ratio [OR] 0.68, 95% CI 0.35-1.31). In 203 women who received emergency contraception between 72 h and 120 h after sexual intercourse, there were three pregnancies, all of which were in the levonorgestrel group. The most frequent adverse event was headache (ulipristal acetate, 213 events [19.3%] in 1104 women; levonorgestrel, 211 events [18.9%] in 1117 women). Two serious adverse events were judged possibly related to use of emergency contraception; a case of dizziness in the ulipristal acetate group and a molar pregnancy in the levonorgestrel group. In the meta-analysis (0-72 h), there were 22 (1.4%) pregnancies in 1617 women in the ulipristal acetate group and 35 (2.2%) in 1625 women in the levonorgestrel group (OR 0.58, 0.33-0.99; p=0.046).
Interpretation: Ulipristal acetate provides women and health-care providers with an effective alternative for emergency contraception that can be used up to 5 days after unprotected sexual intercourse.
Funding: HRA Pharma.
Copyright 2010 Elsevier Ltd. All rights reserved.
Comment in
-
Towards more effective emergency contraception?Lancet. 2010 Feb 13;375(9714):527-8. doi: 10.1016/S0140-6736(10)60146-8. Lancet. 2010. PMID: 20159273 No abstract available.
-
Ulipristal acetate for emergency contraception?Lancet. 2010 May 8;375(9726):1607-8; author reply 1608. doi: 10.1016/S0140-6736(10)60699-X. Lancet. 2010. PMID: 20452518 No abstract available.
-
Ulipristal acetate for emergency contraception?Lancet. 2010 May 8;375(9726):1608; author reply 1608. doi: 10.1016/S0140-6736(10)60700-3. Lancet. 2010. PMID: 20452519 No abstract available.
Similar articles
-
Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation.Hum Reprod. 2016 Jun;31(6):1200-7. doi: 10.1093/humrep/dew055. Epub 2016 Apr 6. Hum Reprod. 2016. PMID: 27052501
-
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.Hum Reprod. 2016 Mar;31(3):530-40. doi: 10.1093/humrep/dev341. Epub 2016 Jan 31. Hum Reprod. 2016. PMID: 26830816 Free PMC article. Clinical Trial.
-
Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception.Clin Ther. 2012 Jan;34(1):24-36. doi: 10.1016/j.clinthera.2011.11.012. Epub 2011 Dec 9. Clin Ther. 2012. PMID: 22154199 Review.
-
Ulipristal acetate for emergency contraception.Ann Pharmacother. 2011 Jun;45(6):780-6. doi: 10.1345/aph.1P704. Epub 2011 Jun 10. Ann Pharmacother. 2011. PMID: 21666089 Review.
-
Update on emergency contraception.Adv Ther. 2011 Feb;28(2):87-90. doi: 10.1007/s12325-010-0090-x. Epub 2010 Dec 10. Adv Ther. 2011. PMID: 21153722 Review.
Cited by
-
Contraception in patients with liver disease and liver transplant.Clin Liver Dis (Hoboken). 2024 Feb 20;23(1):e0104. doi: 10.1097/CLD.0000000000000104. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38379765 Free PMC article. Review.
-
Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: An exploratory study.Contraception. 2024 Apr;132:110370. doi: 10.1016/j.contraception.2024.110370. Epub 2024 Jan 15. Contraception. 2024. PMID: 38232940
-
Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study.Contraception. 2024 Mar;131:110344. doi: 10.1016/j.contraception.2023.110344. Epub 2023 Nov 25. Contraception. 2024. PMID: 38008305
-
The role of legal medicine professionals in preventing pregnancy and sexually transmitted infections among female victims of sexual assault.Forensic Sci Med Pathol. 2023 Sep;19(3):440-451. doi: 10.1007/s12024-023-00578-6. Epub 2023 Mar 7. Forensic Sci Med Pathol. 2023. PMID: 36881378 Free PMC article. Review.
-
Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC).Cureus. 2022 Nov 28;14(11):e31959. doi: 10.7759/cureus.31959. eCollection 2022 Nov. Cureus. 2022. PMID: 36600871 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources